COMMUNIQUÉ DE PRESSE
News
-
-
COMMUNIQUÉ DE PRESSE
CGM drives digitization in the healthcare sector and significantly increases revenues and operating profit margin
CompuGroup Medical SE & Co. KGaA (CGM) reports 5% increase in group revenues to EUR 1.19 billion in 2023, driven by digitization in healthcare. Adjusted EBITDA rises 13% to EUR 265 million with a 1.6 percentage point margin improvement -
COMMUNIQUÉ DE PRESSE
TeamViewer delivers double-digit topline growth, strong margin, and 81% basic EPS increase
TeamViewer delivers strong financial results for FY 2023, with 11% revenue growth and 81% increase in basic EPS. The company also announces a share buyback program of up to EUR 150m for 2023/2024 -
COMMUNIQUÉ DE PRESSE
Contract wins - Kontron signs 3 major railway contracts worth exceeding EUR 100m
Kontron AG announces winning major railway contracts in Ireland, Austria, and Slovenia worth exceeding EUR 100m. The contracts will ensure the continued evolution of the GSM-R system until the transition to Future Railway Mobile Communication Systems (FRMCS) -
COMMUNIQUÉ DE PRESSE
Energy Transition “Made in Europe”: Otovo and Meyer Burger Launch Collaboration
Otovo and Meyer Burger have launched a partnership to offer high-quality European solar products, aiming to strengthen the energy transition. The collaboration will bring resilience and sustainability to the European solar market through digital innovation and local value chains -
COMMUNIQUÉ DE PRESSE
Moderna Chief Executive Officer Stéphane Bancel Elected to National Academy of Engineering
Moderna, Inc.'s CEO Stéphane Bancel elected to National Academy of Engineering for distinguished contributions to engineering and manufacturing of pharmaceutical products, including COVID-19 vaccine. Company has 45 mRNA therapeutic and vaccine programs in pipeline -
COMMUNIQUÉ DE PRESSE
2nd Latin American Nicotine and Risk Reduction Forum in Panama
Global Experts Highlighted the Importance of Reduced-Risk Alternatives in the Comprehensive Fight Against Smoking. RAUDER organized the 2nd Latin American Nicotine and Risk Reduction Forum emphasizing harm reduction, human rights, and science-based regulation -
COMMUNIQUÉ DE PRESSE
Sartorius Stedim Biotech SA: Sartorius Stedim Biotech S.A. réalise avec succès une augmentation de capital avec suppression du droit préférentiel de souscription des actionnaires pour un montant d’env
Sartorius Stedim Biotech S.A. réalise avec succès une augmentation de capital de 1,2 milliard d'euros via un placement privé international -
COMMUNIQUÉ DE PRESSE
Sartorius Stedim Biotech SA: Sartorius Stedim Biotech S.A. successfully completes a EUR 1.2 billion share capital increase without shareholders’ preferential subscription rights
Sartorius Stedim Biotech S.A. successfully completes a EUR 1.2 billion share capital increase without shareholders’ preferential subscription rights. The company aims to use the proceeds to accelerate debt deleveraging and strengthen strategic flexibility. Sartorius AG subscribed for approximately 400 million euros, representing approximately one-third of the Capital Increase -
COMMUNIQUÉ DE PRESSE
EQS-Adhoc: SARTORIUS AG: Sartorius successfully completes placement of 200 million euros of treasury preference shares
Sartorius AG completes placement of 200 million euros of treasury preference shares through an accelerated bookbuilding process, with proceeds set to strengthen the company's strategic flexibility and debt reduction
